Results 221 to 230 of about 93,278 (263)
Some of the next articles are maybe not open access.

Newer antihypertensive drugs

Current Opinion in CARDIOLOGY, 1995
We review three new classes of antihypertensive drugs: imidazolines, monatepil, and neutral endopeptidase inhibitors. Imidazolines are a new generation of central acting drugs. Because of their greater affinity for imidazoline receptors rather than alpha 2-adrenoreceptors, they cause less fatigue and dry mouth than the older central acting drugs ...
J R, Gregoire, S G, Sheps
openaire   +2 more sources

Pharmacology of Antihypertensive Drugs

Journal of Obstetric, Gynecologic & Neonatal Nursing, 1999
The wide variety of first-line agents available for managing high blood pressure include diuretics, beta adrenergic receptor blockers, alpha adrenergic receptor blockers, angiotensin converting enzyme inhibitors, and calcium channel blockers. Supplemental agents used for second-line therapy and special indications, such as pregnancy and hypertensive ...
openaire   +2 more sources

NEW ANTIHYPERTENSION DRUGS

JAMA: The Journal of the American Medical Association, 1952
To the Editor:— Recent announcements in the press of a method to control hypertension by the use of hexamethonium chloride and hydrazinophthalazine have inspired considerable confusion and conflicting comments in both lay and medical circles. Some tabloid newspapers gave a distorted, overenthusiastic view, other papers were reasonably factual, but ...
openaire   +2 more sources

Antihypertensive drug interactions

Drugs of Today, 2005
There are many drug interactions with antihypertensive agents and some of these are highly significant. Patients with hypertension frequently take multiple medications and may be at increased risk for drug interactions. Nearly every elderly patient with multiple medical problems will have the potential for one drug interaction in their regimen.
openaire   +3 more sources

Antihypertensive Drug Therapy

Archives of Internal Medicine, 1965
WE BELIEVE we are now in an era in the empiric treatment of hypertension, when a huge uncontrolled clinical-pharmacological experiment may be masquerading as a clinically acceptable therapy. There can be little doubt that the disabling and lethal agent in chronic hypertensive disease is not the blood pressure level but the associated arterial and ...
W, GOLDRING, H, CHASIS
openaire   +2 more sources

Antihypertensive Drug Therapy

Drugs, 1973
In general, the treatment of hypertension is very rewarding: headache and symptoms of heart failure are relieved, retinopathy regresses, hypertensive encephalopathy is prevented, the likelihood of cerebrovascular accidents is much less, and renal deterioration is halted or slowed.
openaire   +2 more sources

Antihypertensive drugs in Japan

The Lancet, 2001
S, Teramoto, H, Kume, Y, Fukuchi
openaire   +2 more sources

Antihypertensive Drugs

Annual Review of Medicine, 1955
openaire   +2 more sources

Antihypertensive Drug Action

Annual Review of Pharmacology, 1965
E G, PARDO, R, VARGAS, H, VIDRIO
openaire   +2 more sources

Clinical Applicability of Monitoring Antihypertensive Drug Levels in Blood

Hypertension, 2020
Teun Van Gelder   +2 more
exaly  

Home - About - Disclaimer - Privacy